Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.

Calamaras TD, Baumgartner RA, Aronovitz MJ, McLaughlin AL, Tam K, Richards DA, Cooper CW, Li N, Baur WE, Qiao X, Wang GR, Davis RJ, Kapur NK, Karas RH, Blanton RM.

Am J Physiol Heart Circ Physiol. 2019 Jan 1;316(1):H145-H159. doi: 10.1152/ajpheart.00029.2018. Epub 2018 Oct 26.

PMID:
30362822
2.

Trypanosoma cruzi Neurotrophic Factor Facilitates Cardiac Repair in a Mouse Model of Chronic Chagas Disease.

Ledoux T, Aridgides D, Salvador R, Ngwenyama N, Panagiotidou S, Alcaide P, Blanton RM, Perrin MA.

J Pharmacol Exp Ther. 2019 Jan;368(1):11-20. doi: 10.1124/jpet.118.251900. Epub 2018 Oct 22.

PMID:
30348750
3.

What can haemodynamic profiles teach us about heart failure in the paediatric population?

Blanton RM.

Eur Heart J. 2017 Oct 7;38(38):2910-2911. doi: 10.1093/eurheartj/ehx548. No abstract available.

PMID:
29019618
4.

Th1 effector T cells selectively orchestrate cardiac fibrosis in nonischemic heart failure.

Nevers T, Salvador AM, Velazquez F, Ngwenyama N, Carrillo-Salinas FJ, Aronovitz M, Blanton RM, Alcaide P.

J Exp Med. 2017 Nov 6;214(11):3311-3329. doi: 10.1084/jem.20161791. Epub 2017 Oct 2.

5.

Reduced activin receptor-like kinase 1 activity promotes cardiac fibrosis in heart failure.

Morine KJ, Qiao X, Paruchuri V, Aronovitz MJ, Mackey EE, Buiten L, Levine J, Ughreja K, Nepali P, Blanton RM, Oh SP, Karas RH, Kapur NK.

Cardiovasc Pathol. 2017 Nov - Dec;31:26-33. doi: 10.1016/j.carpath.2017.07.004. Epub 2017 Jul 18.

6.

Short-Term Administration of Serelaxin Produces Predominantly Vascular Benefits in the Angiotensin II/L-NAME Chronic Heart Failure Model.

McCarthy JC, Aronovitz M, DuPont JJ, Calamaras TD, Jaffe IZ, Blanton RM.

JACC Basic Transl Sci. 2017 Jun 26;2(3):285-296. doi: 10.1016/j.jacbts.2017.03.011. eCollection 2017 Jun.

7.

Endothelial mineralocorticoid receptor contributes to systolic dysfunction induced by pressure overload without modulating cardiac hypertrophy or inflammation.

Salvador AM, Moss ME, Aronovitz M, Mueller KB, Blanton RM, Jaffe IZ, Alcaide P.

Physiol Rep. 2017 Jun;5(12). pii: e13313. doi: 10.14814/phy2.13313.

8.

Cardiac Myosin Protein C: New Roles, New Questions, Potential Opportunities.

Blanton RM, Alcaide P.

JACC Basic Transl Sci. 2017 Apr 24;2(2):132-134. doi: 10.1016/j.jacbts.2017.03.007. eCollection 2017 Apr. No abstract available.

9.

Conditional knockout of activin like kinase-1 (ALK-1) leads to heart failure without maladaptive remodeling.

Morine KJ, Qiao X, Paruchuri V, Aronovitz MJ, Mackey EE, Buiten L, Levine J, Ughreja K, Nepali P, Blanton RM, Karas RH, Oh SP, Kapur NK.

Heart Vessels. 2017 May;32(5):628-636. doi: 10.1007/s00380-017-0955-x. Epub 2017 Feb 17.

10.

Intercellular Adhesion Molecule 1 Regulates Left Ventricular Leukocyte Infiltration, Cardiac Remodeling, and Function in Pressure Overload-Induced Heart Failure.

Salvador AM, Nevers T, Velázquez F, Aronovitz M, Wang B, Abadía Molina A, Jaffe IZ, Karas RH, Blanton RM, Alcaide P.

J Am Heart Assoc. 2016 Mar 15;5(3):e003126. doi: 10.1161/JAHA.115.003126.

11.

Molecular Screen Identifies Cardiac Myosin-Binding Protein-C as a Protein Kinase G-Iα Substrate.

Thoonen R, Giovanni S, Govindan S, Lee DI, Wang GR, Calamaras TD, Takimoto E, Kass DA, Sadayappan S, Blanton RM.

Circ Heart Fail. 2015 Nov;8(6):1115-22. doi: 10.1161/CIRCHEARTFAILURE.115.002308. Epub 2015 Oct 18.

12.

Left Ventricular T-Cell Recruitment Contributes to the Pathogenesis of Heart Failure.

Nevers T, Salvador AM, Grodecki-Pena A, Knapp A, Velázquez F, Aronovitz M, Kapur NK, Karas RH, Blanton RM, Alcaide P.

Circ Heart Fail. 2015 Jul;8(4):776-87. doi: 10.1161/CIRCHEARTFAILURE.115.002225. Epub 2015 May 28.

13.

Signaling Pathways and Gene Regulatory Networks in Cardiomyocyte Differentiation.

Parikh A, Wu J, Blanton RM, Tzanakakis ES.

Tissue Eng Part B Rev. 2015 Aug;21(4):377-92. doi: 10.1089/ten.TEB.2014.0662. Epub 2015 May 11. Review.

14.

Exposure to experimental preeclampsia in mice enhances the vascular response to future injury.

Pruthi D, Khankin EV, Blanton RM, Aronovitz M, Burke SD, McCurley A, Karumanchi SA, Jaffe IZ.

Hypertension. 2015 Apr;65(4):863-70. doi: 10.1161/HYPERTENSIONAHA.114.04971. Epub 2015 Feb 23.

15.

PDE5 inhibitor efficacy is estrogen dependent in female heart disease.

Sasaki H, Nagayama T, Blanton RM, Seo K, Zhang M, Zhu G, Lee DI, Bedja D, Hsu S, Tsukamoto O, Takashima S, Kitakaze M, Mendelsohn ME, Karas RH, Kass DA, Takimoto E.

J Clin Invest. 2014 Jun;124(6):2464-71. doi: 10.1172/JCI70731. Epub 2014 May 16.

16.

Glycogen synthase kinase-3β inhibition ameliorates cardiac parasympathetic dysfunction in type 1 diabetic Akita mice.

Zhang Y, Welzig CM, Picard KL, Du C, Wang B, Pan JQ, Kyriakis JM, Aronovitz MJ, Claycomb WC, Blanton RM, Park HJ, Galper JB.

Diabetes. 2014 Jun;63(6):2097-113. doi: 10.2337/db12-1459. Epub 2014 Jan 23.

17.

Protein kinase G I and heart failure: Shifting focus from vascular unloading to direct myocardial antiremodeling effects.

Kong Q, Blanton RM.

Circ Heart Fail. 2013 Nov;6(6):1268-83. doi: 10.1161/CIRCHEARTFAILURE.113.000575. Review. No abstract available.

18.

Steroid-sensitive gene 1 is a novel cyclic GMP-dependent protein kinase I substrate in vascular smooth muscle cells.

Wang GR, Surks HK, Tang KM, Zhu Y, Mendelsohn ME, Blanton RM.

J Biol Chem. 2013 Aug 23;288(34):24972-83. doi: 10.1074/jbc.M113.456244. Epub 2013 Jul 6.

19.

Mutation of the protein kinase I alpha leucine zipper domain produces hypertension and progressive left ventricular hypertrophy: a novel mouse model of age-dependent hypertensive heart disease.

Blanton RM, Takimoto E, Aronovitz M, Thoonen R, Kass DA, Karas RH, Mendelsohn ME.

J Gerontol A Biol Sci Med Sci. 2013 Nov;68(11):1351-5. doi: 10.1093/gerona/glt042. Epub 2013 May 8.

20.

Protein kinase g iα inhibits pressure overload-induced cardiac remodeling and is required for the cardioprotective effect of sildenafil in vivo.

Blanton RM, Takimoto E, Lane AM, Aronovitz M, Piotrowski R, Karas RH, Kass DA, Mendelsohn ME.

J Am Heart Assoc. 2012 Oct;1(5):e003731. doi: 10.1161/JAHA.112.003731. Epub 2012 Oct 25.

21.

Conversion of infarction-associated atrial fibrillation by restoration of atrial perfusion.

Blanton RM, Nappi A, Kimmelstiel CD.

Clin Cardiol. 2010 Dec;33(12):E79-81. doi: 10.1002/clc.20573.

22.

Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy.

Chiu HC, Kovacs A, Blanton RM, Han X, Courtois M, Weinheimer CJ, Yamada KA, Brunet S, Xu H, Nerbonne JM, Welch MJ, Fettig NM, Sharp TL, Sambandam N, Olson KM, Ory DS, Schaffer JE.

Circ Res. 2005 Feb 4;96(2):225-33. Epub 2004 Dec 23.

PMID:
15618539

Supplemental Content

Loading ...
Support Center